Viewing StudyNCT06384352

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 8:26 PM
Last Modification Date: 2024-10-26 @ 3:27 PM
Study NCT ID: NCT06384352
Status: RECRUITING
Last Update Posted: 2024-05-10
First Post: 2024-03-26
Brief Title: A Phase I Study to Evaluate the SafetyTolerability Pharmacokinetics and Efficacy of YL211 in Patients With Advanced Solid Tumors
Sponsor: MediLink Therapeutics Suzhou Co Ltd
Organization: MediLink Therapeutics Suzhou Co Ltd
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Advanced Solid Tumors
Keywords: